AMED - Amedisys, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
197.51
+5.50 (+2.86%)
As of 9:51AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close192.01
Open197.67
Bid197.30 x 800
Ask197.97 x 1100
Day's Range197.00 - 198.48
52 Week Range108.10 - 218.44
Volume22,059
Avg. Volume318,261
Market Cap6.395B
Beta (5Y Monthly)0.88
PE Ratio (TTM)51.30
EPS (TTM)3.85
Earnings DateJul. 29, 2020 - Aug. 03, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est211.46
  • GlobeNewswire

    Amedisys to Present at RBC Capital Markets 2020 Global Healthcare Conference

    Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at RBC Capital Markets 2020 Global Healthcare Conference on Tuesday, May 19, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.

  • GlobeNewswire

    Amedisys to Present at the UBS Virtual Global Healthcare Conference 2020

    Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the UBS Global Healthcare Conference 2020 on Monday, May 18, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.

  • Thomson Reuters StreetEvents

    Edited Transcript of AMED earnings conference call or presentation 7-May-20 3:00pm GMT

    Q1 2020 Amedisys Inc Earnings Call

  • Amedisys (AMED) Beats Q1 Earnings Estimates
    Zacks

    Amedisys (AMED) Beats Q1 Earnings Estimates

    Amedisys (AMED) delivered earnings and revenue surprises of 8.25% and -4.02%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Amedisys Reports First Quarter 2020 Financial Results

    BATON ROUGE, La., May 06, 2020 -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2020. Three-Month Periods Ended.

  • Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio
    Zacks

    Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio

    Interest Coverage Ratio suggests how many times the interest could be paid from earnings and gauges the margin of safety a firm has for paying interest.

  • A Look At The Intrinsic Value Of Amedisys, Inc. (NASDAQ:AMED)
    Simply Wall St.

    A Look At The Intrinsic Value Of Amedisys, Inc. (NASDAQ:AMED)

    Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Amedisys, Inc...

  • GlobeNewswire

    Amedisys Celebrates More Than 8,000 Nurses During National Nurses Month

    Amedisys, Inc. (AMED), one of the nation’s leading home healthcare, hospice and personal care companies, celebrates National Nurses Month by honoring more than 8,000 nurses who call the company home. Traditionally, National Nurses Week begins each year on May 6 and ends on May 12, Florence Nightingale’s birthday. With the World Health Organization declaring 2020 as the Year of the Nurse and Midwife, this celebration has been extended to the entire month.

  • GlobeNewswire

    Amedisys to Present at the BofA Securities 2020 Virtual Health Care Conference

    Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the BofA Securities 2020 Virtual Health Care Conference on Tuesday, May 12, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.

  • Earnings Preview: Amedisys (AMED) Q1 Earnings Expected to Decline
    Zacks

    Earnings Preview: Amedisys (AMED) Q1 Earnings Expected to Decline

    Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    Amedisys Signs Definitive Agreement to Acquire AseraCare Hospice

    Amedisys, Inc. (AMED), a leading provider of home health, hospice and personal care, announced today that it has, through one of its wholly owned subsidiaries, signed a definitive agreement to acquire Homecare Preferred Choice, Inc., doing business as AseraCare Hospice (“AseraCare Hospice”), a national hospice care provider with an executive office in Plano, Texas and administrative support center in Fort Smith, Arkansas. Founded in 1994, AseraCare Hospice cares for more than 2,100 patients daily and employs more than 1,200 hospice professionals in 44 locations across 14 states, generating approximately $117 million in annual revenues. Under the terms of the agreement, expected to close on, or around, June 1, 2020, pending regulatory approvals, Amedisys will acquire 100 percent of the ownership interests in AseraCare Hospice for a cash purchase price of $235 million, which is inclusive of a $32 million tax asset bringing the net purchase price to $203 million.

  • 3 Reasons Why Growth Investors Shouldn't Overlook Amedisys (AMED)
    Zacks

    3 Reasons Why Growth Investors Shouldn't Overlook Amedisys (AMED)

    Amedisys (AMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

  • Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?
    Zacks

    Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?

    Is (AMED) Outperforming Other Medical Stocks This Year?

  • Amedisys (AMED) Is Up 8.62% in One Week: What You Should Know
    Zacks

    Amedisys (AMED) Is Up 8.62% in One Week: What You Should Know

    Does Amedisys (AMED) have what it takes to be a top stock pick for momentum investors? Let's find out.

  • Amedisys (AMED) Upgraded to Buy: Here's Why
    Zacks

    Amedisys (AMED) Upgraded to Buy: Here's Why

    Amedisys (AMED) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Amedisys (AMED) Hits 52-Week High, Can the Run Continue?
    Zacks

    Amedisys (AMED) Hits 52-Week High, Can the Run Continue?

    Amedisys (AMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • How Does Amedisys's (NASDAQ:AMED) P/E Compare To Its Industry, After Its Big Share Price Gain?
    Simply Wall St.

    How Does Amedisys's (NASDAQ:AMED) P/E Compare To Its Industry, After Its Big Share Price Gain?

    Amedisys (NASDAQ:AMED) shares have had a really impressive month, gaining 45%, after some slippage. Looking back a bit...

  • GlobeNewswire

    Amedisys Announces First Quarter Earnings Release and Conference Call Date

    Amedisys, Inc. (AMED), announced today that it will report results for the first quarter ended March 31, 2020, after the market closes on May 6, 2020. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on May 7, 2020. To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (Toll-Free) or (412) 902-1028 (Toll).

  • What Is Amedisys, Inc.'s (NASDAQ:AMED) Share Price Doing?
    Simply Wall St.

    What Is Amedisys, Inc.'s (NASDAQ:AMED) Share Price Doing?

    Amedisys, Inc. (NASDAQ:AMED), which is in the healthcare business, and is based in United States, received a lot of...

  • Amedisys (AMED) Stock Moves -0.87%: What You Should Know
    Zacks

    Amedisys (AMED) Stock Moves -0.87%: What You Should Know

    In the latest trading session, Amedisys (AMED) closed at $168.20, marking a -0.87% move from the previous day.

  • Here's Why You Should Retain Amedisys (AMED) Stock for Now
    Zacks

    Here's Why You Should Retain Amedisys (AMED) Stock for Now

    Investor confidence is high in Amedisys (AMED) stock, thanks to solid prospects.

  • Why Is Amedisys (AMED) Down 16.2% Since Last Earnings Report?
    Zacks

    Why Is Amedisys (AMED) Down 16.2% Since Last Earnings Report?

    Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • The Amedisys (NASDAQ:AMED) Share Price Is Up 549% And Shareholders Are Delighted
    Simply Wall St.

    The Amedisys (NASDAQ:AMED) Share Price Is Up 549% And Shareholders Are Delighted

    We think all investors should try to buy and hold high quality multi-year winners. And highest quality companies can...

  • GlobeNewswire

    Amedisys to Present at the Oppenheimer 30th Annual Healthcare Conference

    Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Oppenheimer 30th Annual Healthcare Conference in New York, N.Y. on Tuesday, March 17, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.

  • Amedisys  Breaks Out To New Highs
    Investor's Business Daily Video

    Amedisys Breaks Out To New Highs

    Amedisys, a nursing home care provider, broke out over a 202.86 entry after clearing an early entry at 190.50 last week. This was an outside day for a long-term leader.